| Primary |
| Asthma |
57.9% |
| Chronic Obstructive Pulmonary Disease |
12.4% |
| Hypertension |
3.5% |
| Bronchitis |
3.5% |
| Dyspnoea |
3.0% |
| Emphysema |
2.6% |
| Cough |
2.2% |
| Multiple Allergies |
2.0% |
| Hypersensitivity |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Pneumonia |
1.2% |
| Osteoporosis |
1.2% |
| Lung Infection |
1.0% |
| Rhinitis |
1.0% |
| Wheezing |
1.0% |
| Hepatic Cirrhosis |
0.9% |
| Hepatitis C |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Pain |
0.9% |
| Prophylaxis |
0.9% |
|
| Dyspnoea |
18.8% |
| Asthma |
15.0% |
| Drug Ineffective |
9.5% |
| Off Label Use |
9.5% |
| Drug Dose Omission |
9.1% |
| Malaise |
7.5% |
| Wheezing |
4.4% |
| Cough |
3.3% |
| Pneumonia |
2.9% |
| Palpitations |
2.2% |
| Throat Irritation |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Pharmaceutical Product Complaint |
2.0% |
| Death |
1.8% |
| Muscular Weakness |
1.8% |
| Osteonecrosis |
1.8% |
| Weight Decreased |
1.8% |
| Blood Glucose Increased |
1.5% |
| Oedema Peripheral |
1.5% |
| Pruritus |
1.5% |
|
| Secondary |
| Asthma |
31.6% |
| Chronic Obstructive Pulmonary Disease |
18.3% |
| Drug Use For Unknown Indication |
8.3% |
| Product Used For Unknown Indication |
5.1% |
| Hypertension |
4.3% |
| Supraventricular Tachycardia |
3.4% |
| Epilepsy |
3.3% |
| Thrombosis Prophylaxis |
2.7% |
| Dermatitis |
2.6% |
| Prophylaxis |
2.6% |
| Pneumonia |
2.3% |
| Grand Mal Convulsion |
2.0% |
| Rash |
2.0% |
| Cardiac Failure |
1.9% |
| Cough |
1.9% |
| Tachycardia Paroxysmal |
1.8% |
| Bronchitis Chronic |
1.6% |
| Emphysema |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Multiple Allergies |
1.4% |
|
| Drug Ineffective |
12.0% |
| Toxic Epidermal Necrolysis |
11.6% |
| Off Label Use |
10.4% |
| Dyspnoea |
7.2% |
| Asthma |
6.8% |
| Wheezing |
5.2% |
| Vomiting |
4.8% |
| Drug Dose Omission |
4.0% |
| Malaise |
4.0% |
| Throat Irritation |
4.0% |
| Urticaria |
3.6% |
| Fatigue |
3.2% |
| Sinusitis |
3.2% |
| Weight Increased |
3.2% |
| Adrenal Insufficiency |
2.8% |
| Palpitations |
2.8% |
| Tachycardia |
2.8% |
| Thrombocytopenia |
2.8% |
| Weight Decreased |
2.8% |
| Interstitial Lung Disease |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.2% |
| Asthma |
20.5% |
| Drug Use For Unknown Indication |
16.1% |
| Chronic Obstructive Pulmonary Disease |
6.4% |
| Hypertension |
4.2% |
| Pain |
2.7% |
| Hypersensitivity |
2.5% |
| Osteoporosis |
2.1% |
| Prophylaxis |
1.8% |
| Depression |
1.6% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Atrial Fibrillation |
1.3% |
| Dyspnoea |
1.2% |
| Diabetes Mellitus |
1.2% |
| Anxiety |
1.1% |
| Emphysema |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Crohn's Disease |
1.0% |
| Constipation |
0.9% |
|
| Vomiting |
14.3% |
| Pneumonia |
8.4% |
| Dyspnoea |
8.2% |
| Wheezing |
7.3% |
| Asthma |
5.8% |
| Weight Decreased |
5.4% |
| Drug Ineffective |
5.0% |
| Nausea |
4.5% |
| Weight Increased |
4.5% |
| Urticaria |
4.3% |
| Pyrexia |
3.7% |
| Death |
3.6% |
| Respiratory Failure |
3.5% |
| Pulmonary Embolism |
3.4% |
| Tremor |
3.3% |
| Urinary Tract Infection |
3.1% |
| Vision Blurred |
3.1% |
| Sinusitis |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Headache |
2.8% |
|
| Interacting |
| Asthma |
37.5% |
| Bronchitis |
12.5% |
| Cellulitis |
12.5% |
| Depression |
12.5% |
| Essential Hypertension |
12.5% |
| Fungal Infection |
12.5% |
|
| Enamel Anomaly |
40.0% |
| Drug Interaction |
20.0% |
| Gastrooesophageal Reflux Disease |
20.0% |
| Scedosporium Infection |
20.0% |
|
